Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-662 PK/Safety in Japanese Patients with Congenital Protein C Deficiency
NCT04984889Phase 2Completed
- Sponsor
- Takeda
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of protein C in congenital protein C deficiency, sponsored by Takeda. Started Sep 2021; status: completed.
02
Drugs
protein C
03
Conditions
congenital protein C deficiency
Beyond the preview
Go deeper on NCT04984889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04984889.